LexDanaLexDanabeta
Inventor

OLAF GRASSMANN

Inventor
US

Overview

4→
Patents
2023–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07BGeneral methods of organic chemistry25%
C07DHeterocyclic compounds25%
A61KPreparations for medical, dental or toiletry purposes17%
PatentTitleYear
12,459,947Synthesis of trans-8-chloro-5-methyl-1 -[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H-2,3,5,10B-tetraaza-benzo[e]azulene and crystalline forms thereof202512,134,599Solid forms202411,938,136Compositions for treating spinal muscular atrophy202411,814,354Solid forms2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2025Patents assigned to HOFFMANN LA ROCHE (4)· patent assignee history
2023–2024Patents assigned to RIVER 3 RENAL CORP (2)· patent assignee history
2023–2024Based in US· patent location history
2024Based in CH· patent location history
2025Based in DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
HOFFMANN LA ROCHE42023–2025
RIVER 3 RENAL CORP22023–2024
Locations
LocationPatentsSpan
US22023–2024
DE12025
CH12024